INFUSION SITE FIBROSIS

This adverse event was reported 20 times

INFUSION SITE FIBROSIS is most prevalent among patients taking these drugs:

# Drug Count Frequency
0 PSYLLIUM HUSK 1 0.0007
1 BUPIVACAINE HYDROCHLORIDE IN DEXTROSE 5 0.0007
2 BUPIVACAINE 5 0.0005
3 CALCIUM POLYCARBOPHIL 1 0.0003
4 SELEGILINE 1 0.0003
5 FOSCARBIDOPA/FOSLEVODOPA 1 0.0001
6 BACLOFEN 9 0.0001
7 ROPINIROLE 1 0.0001
8 CLONIDINE 3 0.0001
9 HUMAN IMMUNOGLOBULIN G 1 0.0000
See all drugs enriched for association with INFUSION SITE FIBROSIS